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Case Report
A 28-year-old Nigerian poultry farmer presented to MMSH 
Kano in February 2009, on account of 2 year’s history of 
progressive dyspnea on exertion, weight loss, dry cough, 
neck swelling, decreased appetite, and fatigue.
There was no history of syncope or dysphagia. No history 
of contact with chronic cough. He had never smoked 
cigarettes. He was diagnosed earlier at Peripheral Hospital 
as sputa negative PTB; hence he was given 6-month-course 
DOTS treatment with little or no improvement.
Clinical examination revealed a young man wasted 48 kg, 
cervical lymph nodes, dyspnoic, tachypnoic at rest. HR 
was 120 beats per minute, RR 28 breaths per minute, and 
superficial vascular distention over the neck, chest, and 
upper abdomen (nonpulsatile). There was no stridor, but 
coarse basal crackles in the chest posteriorly. Abomininal 
examination revealed hepatoslenomegaly – an impression of 
superior vena cava syndrome? Cause was entertained. Urgent 
chest X-ray and abdominal ultrasound were ordered,
The results showed the following.
Abdominal ultrasound and CT abdomen showed evidence 
of multiple abdominal masses.
Provisional diagnosis of disseminated tuberculosis was 
entertained based on the following:
History, chest involvement, deranged LFTs [Table 1], 
hepatosplenomegaly and abdominal masses on CT, and 
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Table 1: Haematology and chemistry profile
FBC/ESR LFTs
Hb 13.0 g/dl Albumin 26 g/dl
WBC 8.0 × 109/l Bilurbin – 6.04 mm/l
Platelets 410 × 109/l Alp Phosph – 307 mg/dl
ESR 23 mm/h SGOT – 733 iu/l
U/E/Cr SGPT – 502 iu/l
Na – 134 mm/l ALT – 46 iu/l
K – 4.7 mm/l 
Ch – 106 mm/l  
HCO
3
 – 23 mm/l
Creatinine – 86 umo/l
Others 
Fasting sugar – 4.7 mm/l 
Mantoux test – 10 mm
Urine vanyl mandelic 
acid – normal 
Serum ACTH levels – normal 
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cervical lymph nodes. Other differential diagnosis considered 
include fungal infection, lymphoma, thymoma, metastatic 
carcinoma, pheochromocytoma. Hence, further investigations 
were requested. A fine needle aspiration biopsy (FNAB) of 
cervical lymph node showed reactive changes.
Routine blood cultures were done, and no growth was found. 
Sputum acid fast bacilli (AFB) on three separate occasions 
were negative. Serology was negative for cryptococcus and 
HIV. Bone marrow aspiration showed mild reactive changes 
only. FNAB fungal staining showed yeast cells on microscopy
Broncoscopy and alveolar lavage were rewarding, as it 
clinches the diagnosis of disseminated histoplasmosis. 
Culture yields histoplasma capsulatum
He was discharged home on fluconazole 200 mg b.d. for 
1 month, seen at follow-up chest clinic after 3 months, doing 
well, a febrile gaining weight, 53 kg in May 2009
Discussions
Superior vena cava syndrome encompasses a constellation 
of symptoms and signs resulting from obstruction of 
the superior vena cava. The increased venous pressure 
in the upper body results in edema of the head, neck, 
and aims, often with cyanosis, plethora, and distended 
subcutaneous vessels may be a consequence of obstruction 
of the superior vena cava (intrinsic or due to extrinsic 
compression), compression of the heart by a large mass 
in the chest, or both.[1] The superior vena cava carries 
blood from the head, arms, and upper torso to the heart; 
it carries approximately one-third of the venous return 
to the heart. When the superior vena cava is obstructed, 
blood flows through a collateral vascular network to the 
lower body and the inferior vena cava or the azygos vein. 
It generally takes several weeks for the venous collaterals 
to dilate sufficiently to accommodate the blood flow of 
the superior vena cava.[2,3] In humans with obstruction 
of the superior vena cava, the cervical venous pressure 
is usually increased to 20 to 40 mm Hg (normal range, 
2–8 mm Hg).[4,5,6] The severity of the symptoms depends 
on the degree of narrowing of the superior vena cava and 
the speed of the onset of the narrowing. Compression of 
the superior vena cava may result from the presence of 
a mass in the middle or anterior mediastinum, consisting 
of enlarged right paratracheal lymph nodes, lymphoma, 
thymoma, an inflammatory process, or an aortic aneurysm. 
Infectious causes e.g. tuberculosis and syphilis accounted for 
the majority of cases and malignant conditions accounted 
for more than 90% of cases approximately in pre HIV era.
Our initial suspicion was rather that of a malignant cause 
of SVC obstruction; however earlier ancillary investigations 
were not in keeping with any of the differentials. It is 
customary for practising physicians to commence anti-TB 
medications as therapeutic trial if patients present with high 
index of clinical suspicion despite negative sputa testing. 
The time frame for the therapeutic trial is not well stated 
in the Nigerian national guidelines for TB treatment.
The occupational history and duration of the exposure to 
high inocula of poultry roost was overlooked. This could 
explain the occurrence of disseminated disease in the 
absence of immunosuppression. In addition this patient 
was also HIV negative; hence the diagnosis was remotely 
considered. Histoplasmosis is one the neglected cause 
of SVC. Few sporadic cases of histoplasmosis have been 
reported in northern Nigeria.
These cases are often seen in immunocompromised 
patients. However, it has been fairly common in our series 
to diagnose this infection authochronous to Kano State, 
especially in patients with initial suspicion of tuberculosis 
with, or without immunosuppression. Histoplasma 
capsulatum is a dimorphic fungus that remains in a mycelial 
form at ambient temperatures and grows as yeast at body 
temperature. Infection causes histoplasmosis, transmitted 
via inhalation and deposition in alveoli.[7] Most individuals 
with histoplasmosis are asymptomatic. Those who develop 
clinical manifestations are usually immunocompromised or 
are exposed to a high quantity of inoculum. Histoplasma 
species may remain latent in healed granulomas and 
recur, resulting in cell-mediated immunity impairment; 
however in our patient no signs of immunosuppression were 
demonstrated. The host defense includes the fungistatic 
properties of neutrophils and macrophages. The lymphocytes 
are crucial in limiting the extent of infection. Susceptibility 
to dissemination is increased markedly with impaired cellular 
host defenses Clinical manifestations of histoplasmosis 
appear with continued exposure to large inocula. The 
initial pulmonary infection may disseminate systemically, 
with hematogenous spread, and produce extrapulmonary 
manifestations. Hematogenous spread to regional lymph 
nodes may occur through the lymphatics or the liver 
and spleen. Progressive disseminated histoplasmosis is 
rare in adult hosts who are immunocompetent. Systemic 
spread usually occurs in patients with impaired cellular 
immunity and typically involves the CNS, liver, spleen, and 
rheumatologic, ocular, and hematologic systems. Progressive 
disseminated histoplasmosis occurs in 1 case per 2000 cases 
in adults who are immunocompetent.[8] It is recommended 
that patients with severe infection should be treated with 
amphotericin B; once the patient is stable, amphotericin B 
may be changed to itraconazole and should be continued 
for 1 year.[9]
The choice of fluconazole in our patient, though not gold 
standard of treatment, was based on the affordability and 
availability in our low resource setting.
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This patient responded well to fluconazole and presently 
been followed up at the hospital chest clinic. Histoplasmosis 
should be suspected in patients within certain epidemiologic 
setting presenting with pneumonia and mediastinal or 
hilar lymphadenopathy, masses suggestive of malignancy 
on chest X-ray, pulmonary nodule, cavitary lung disease 
suggestive of tuberculosis or pericarditis with mediastinal 
lymphadenopathy. The population at risk includes farmers, 
poultry keepers, especially when cleaning chicken coops, 
pigeon roosts, and bat-infested barns or lofts, construction 
workers, especially those who work around old buildings 
with roosting birds, landscapers, archeologists, and geologists. 
Most of risks of severe infection can occur in infants and very 
young children and older adults. The risk of disseminated 
histoplasmosis increases with age. HIV-positive or those with 
AIDS, people receiving chemotherapy or long-term treatment 
with corticosteroid such as prednisone, people who have had 
organ transplants and are taking anti-rejection medications.
Conclusion
Histoplasmosis should be considered as an important 
differential diagnosis of DTB, particularly in individuals 
from endemic areas with or without immunosuppression. 
Clinical features may be similar to disseminated tuberculosis.
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